Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to $444708.0.

  • Biomerica's Gains from Investment Securities fell 8616.61% to $444708.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $444708.0, marking a year-over-year decrease of 8616.61%. This contributed to the annual value of $413866.0 for FY2025, which is 484.83% down from last year.
  • Biomerica's Gains from Investment Securities amounted to $444708.0 in Q4 2025, which was down 8616.61% from $413146.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Gains from Investment Securities registered a high of $3.5 million during Q1 2024, and its lowest value of -$1.0 million during Q2 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $157872.0 (2021), whereas its average is $974797.6.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 11999941.13% in 2021, then plummeted by 1009519.46% in 2022.
  • Quarter analysis of 5 years shows Biomerica's Gains from Investment Securities stood at $2081.0 in 2021, then tumbled by 10095.19% to -$208000.0 in 2022, then skyrocketed by 1196.21% to $2.3 million in 2023, then soared by 40.98% to $3.2 million in 2024, then crashed by 86.17% to $444708.0 in 2025.
  • Its last three reported values are $444708.0 in Q4 2025, $413146.0 for Q3 2025, and $55000.0 during Q2 2025.